Literature DB >> 19965089

Identifying relative cut-off scores with neural networks for interpretation of the Minnesota Living with Heart Failure questionnaire.

Hassan Behlouli1, Deborah E Feldman, Anique Ducharme, Marc Frenette, Nadia Giannetti, François Grondin, Caroline Michel, Richard Sheppard, Louise Pilote.   

Abstract

BACKGROUND: Quality of life (QoL) is an important end point in heart failure (HF) studies. The Minnesota Living with Heart Failure questionnaire (MLHFQ) is the instrument most widely used to evaluate QoL in Heart Failure (HF) patients. It is a questionnaire containing 21 questions with scores ranging from 0 to 105. A best cut-off value for MLHFQ scores to identify those patients with good, moderate or poor QoL has not been determined.
OBJECTIVE: To determine a cut-off score for the MLHFQ based on the neural network (NN) approach. These cut-off scores will help discriminate between HF patients having good, moderate or poor QoL.
METHODS: This research was carried out in the context of a longitudinal cohort study of new patients attending specialized HF clinics in six participating centers in Quebec, Canada. Patients completed a questionnaire that included the MLHFQ. In addition to this scale, self-perceived health status and clinical information related to the severity of HF were obtained including: the New York Heart Association (NYHA) functional class, 6 minute walk test and survival status. We analyzed the database using NN and conventional statistical tools. The NN is a statistical program that recognizes clusters of MLHFQ and relates similar QoL measures to one another. Among the 531 eligible patients, 447 patients with complete questionnaires were used to build randomly two sets for training (learning set) and for testing (validation set) the NN.
RESULTS: Participants had a mean age of 65 years and 24% were women. The median MLHFQ score was 45 (inter-quartile range: 27 to 64). NN identified 3 distinct clusters of MLHFQ that represent the full spectrum of possible scores on the MLHFQ. We estimated that a score of < 24 on the MLHFQ represents a good QoL, a score between 24 and 45 represents a moderate QoL, and a score > 45 represents a poor QoL. Validation with the different severity measures confirmed these categories. These cut-offs allowed us to reach a good total accuracy (91%). These cutoffs were strongly correlated with survival status (p = 0.004), self-perceived health status (p = 0.0032), NYHA functional class (p<0.0001) and standardized 6 minutes walk test (p = 0.05)
CONCLUSION: The identification of three levels of MLHFQ should be useful in clinical decision making.

Entities:  

Mesh:

Year:  2009        PMID: 19965089     DOI: 10.1109/IEMBS.2009.5334659

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  24 in total

1.  Heart-focused anxiety in patients with chronic heart failure before implantation of an implantable cardioverter defibrillator: baseline findings of the Anxiety-CHF Study.

Authors:  Maxie Bunz; Denise Lenski; Sonja Wedegärtner; Christian Ukena; Julia Karbach; Michael Böhm; Ingrid Kindermann
Journal:  Clin Res Cardiol       Date:  2015-10-19       Impact factor: 5.460

2.  Phantom shocks in implantable cardioverter-defibrillator recipients: impact of education level, anxiety, and depression.

Authors:  Swaroop Varghese; J Christoph Geller; Marc-Alexander Ohlow
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2019-08-22

3.  Depressive symptoms, health-related quality of life, and cardiac event-free survival in patients with heart failure: a mediation analysis.

Authors:  Kyoung Suk Lee; Terry A Lennie; Jia-Rong Wu; Martha J Biddle; Debra K Moser
Journal:  Qual Life Res       Date:  2014-02-01       Impact factor: 4.147

4.  Self-care Moderates the Relationship Between Symptoms and Health-Related Quality of Life in Heart Failure.

Authors:  Jonathan P Auld; James O Mudd; Jill M Gelow; Shirin O Hiatt; Christopher S Lee
Journal:  J Cardiovasc Nurs       Date:  2018 May/Jun       Impact factor: 2.083

5.  Circulating levels of a biomarker of collagen metabolism are associated with health-related quality of life in patients with chronic heart failure.

Authors:  Sofia V Chatzikyriakou; Dimitrios N Tziakas; Georgios K Chalikias; Dimitrios Stakos; Dimitrios Papazoglou; Asimina Lantzouraki; Adina Thomaidi; Harisios Boudoulas; Stavros Konstantinides
Journal:  Qual Life Res       Date:  2011-05-20       Impact factor: 4.147

6.  Impact of Melatonin and Branched-Chain Amino Acids Cosupplementation on Quality of Life, Fatigue, and Nutritional Status in Cachectic Heart Failure Patients: A Randomized Controlled Trial.

Authors:  Hamed Jafari-Vayghan; Jalal Moludi; Sevda Saleh-Ghadimi; Elgar Enamzadeh; Mir Hossein Seyed-Mohammadzad; Mohammad Alizadeh
Journal:  Am J Lifestyle Med       Date:  2019-09-14

7.  Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial).

Authors:  Tetz C Lee; Min Qian; Gregory Y H Lip; Marco R Di Tullio; Susan Graham; Douglas L Mann; Koki Nakanishi; John R Teerlink; Ronald S Freudenberger; Ralph L Sacco; J P Mohr; Arthur J Labovitz; Piotr Ponikowski; Dirk J Lok; Conrado Estol; Stefan D Anker; Patrick M Pullicino; Richard Buchsbaum; Bruce Levin; John L P Thompson; Shunichi Homma; Siqin Ye
Journal:  Am J Cardiol       Date:  2018-06-04       Impact factor: 2.778

8.  Evaluation of super-responders to cardiac resynchronization therapy in the presence of left bundle branch block and absence of scar in the posterolateral wall of the left ventricle.

Authors:  Izaias Marques de Sá Junior; José Carlos Pachón Mateos; Juan Carlos Pachón Mateos; Remy Nelson Albornoz Vargas
Journal:  Am J Cardiovasc Dis       Date:  2020-04-15

9.  Left Ventricular Diastolic Dysfunction is Associated with Renal Dysfunction, Poor Survival and Low Health Related Quality of Life in Cirrhosis.

Authors:  Madhumita Premkumar; Devaraja Devurgowda; Tanmay Vyas; Saggere M Shasthry; Jelen S Khumuckham; Ritu Goyal; Sherin S Thomas; Guresh Kumar
Journal:  J Clin Exp Hepatol       Date:  2018-08-30

10.  Does maladaptive cardiovagal modulation extend to gastric modulation in women with chronic pelvic pain?

Authors:  DeWayne Williams; Eric Muth; Julian Thayer; Thomas Chelimsky; Gisela Chelimsky
Journal:  Neurourol Urodyn       Date:  2020-10-12       Impact factor: 2.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.